NPPA revises the MRP of certain additional Non Schedules Anti-Cancer Medicines

May 22, 2019 | by Avantis RegTech Legal Research Team


The National Pharmaceutical Pricing Authority (NPPA) on May 15, 2019, has revised the MRP of certain additional Non Schedules Anti-Cancer Medicines.

Revised MRP of Non Scheduled Anti-Cancer Medicines with effect from March 08, 2019 (Additional List based on data received till May 01, 2019), are as under:

SI. No.

Drug

Strength and Dosage form

Brand Name

Revised MRP

1.

Erlotinib

100mg tablet

Erlotaz (10)

1840

2.

Erlotinib

150mg tablet

Erlotaz (10)

2400

3.

Premetrexed

100mg tablet

Premxcel (1)

800

4.

Premetrexed

500mg tablet

Premxcel (1)

2880

5.

Epirubicin

10mg Injection

Epichlor (1)

276.8

6.

Epirubicin

50mg Injection

Epichlor (1)

960

7.

Leuprolide acetate

3.75mg Injection

Leuprogon Depot (1)

2650

8.

Everolimus

0.25mg tablet

Lanolimus 0.25mg

406

9.

Everolimus

0.5mg tablet

Lanolimus 0.5mg

739


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.